Condition
Glomerular Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Glomerular Disease clinical trials that are recruiting, at sites in 9 countries (most in United States (3), South Korea (2), Argentina (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest Glomerular Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term zigakibart treatment for adults with IgA nephropathy | Phase 3 | Denver, Colorado and 25 other locations | Recruiting | Mar 5, 2025 |
| Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome | — | Ann Arbor, Michigan | Recruiting | Aug 17, 2022 |
| A network for analyzing kidney biopsy data in glomerular diseases | — | Chuncheon and 5 other locations | Recruiting | Apr 29, 2019 |
| Combining Rituximab and Cyclosporine for Membranous Nephropathy | Phase 2 | Bethesda, Maryland and 1 other locations | Recruiting | Sep 16, 2009 |
All recruiting trials (4)
-
Long-term zigakibart treatment for adults with IgA nephropathy
Adults with IgA nephropathy who finished an earlier zigakibart trial will receive ongoing subcutaneous zigakibart every two weeks to see if it stays safe and helps over the long term.
-
Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome
This study talks to patients and parents about their experiences with swelling from Nephrotic Syndrome to help create better ways to measure how new treatments work.
-
A network for analyzing kidney biopsy data in glomerular diseases
This study is trying to build a detailed database of kidney biopsy samples and health information from patients with glomerular diseases to help researchers better understand these conditions and improve treatments.
-
Combining Rituximab and Cyclosporine for Membranous Nephropathy
This study tests if combining two medications, rituximab and cyclosporine, can help people with membranous nephropathy improve their kidney function and reduce protein in their urine.
Related topics
Quick answers
How many Glomerular Disease clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (3 trials), South Korea (2 trials), Argentina (1 trial), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.